Three down, two to go when it comes to major regulatory hurdles that Medtronic and Covidien need to clear for their proposed $43 billion merger. The U.S. Federal Trade Commission, the European Union and Canada’s Competition Bureau ...
Posted in Medical Device Business by Brian Buntz on November 18, 2014 Irvine, CA–based Allergan has been adamant in fighting off a hostile takeover attempt from Valeant Pharmaceuticals International for the past seven months. But ...
Tags: silicone breast, Botox, Health
Covidien described its new Puritan Bennett 980 ventilator as “simple, safe, and smart” when it won regulatory approval in the U.S. and Europe in early 2014. But half a year later, it is now the subject of a Class I-level recall ...
Since Medtronic can’t dip into its considerable foreign cash reserves to buy Covidien, it plans to raise $16 billion domestically toward the $43 billion purchase. Wall Street is not pleased. In a filing late last week with the U.S. ...
Tags: Medtronic, Covidien, Medical Device
Life sciences conglomerate Danaher has announced plans to acquire dental firm Nobel Biocare Holding for $2.1 billion in cash. The deal, assuming it passes regulator muster, could close by the end of this year or early 2015. The move marks ...
Tags: Danaher, Swiss Dental Firm, Medicine
As it prepares for its $43 billion merger with Medtronic, Covidien has purchased a small California medtech company. The price was not disclosed. Privately held Reverse Medical Corp. (Irvine, CA) makes devices to manage acute stroke and ...
Tags: Covidien, Medtech Company, Health
Medtronic isn’t the only medtech company facing criticism over potentially moving its headquarters overseas. Hospira is also taking flak—even though it is only rumored so far to be in talks with French company Danone for a ...
Like the kid on the playground who watches others hop on and off the spinning merry-go-round, Boston Scientific says it will sit out the current whirl of medtech mergers. Following last week’s second-quarter earnings report, ...
CR Bard execs know they have a gorilla of a competitor in the proposed $43 billion Medtronic acquisition of Covidien, particularly in the vascular business. They aren’t predicting the effects of that business combination on Bard, ...
Tags: CR Bard Eyes, Health, Medicine
The medtech jobs picture looked rosy in 2013, with the top 15 device makers in hiring mode, according to an EP Vantage report out this week. Excluding pharmaceutical spinoffs, these companies expanded their collective workforce by 6%, the ...
Tags: Medtech Jobs, Health, Medicine
President Obama clearly doesn’t like Medtronic’s plan to move its headquarters to Ireland through the acquisition of Covidien. Medtronic’s $43 billion acquisition of Covidien would be the largest tax inversion deal yet. ...
Tags: Medtronic-Covidien, Health, Medicine
Medtronic officials apparently see the political blowback over their proposed $43 billion acquisition of Covidien as serious business. The company has paid $200,000 to lobbyists including former U.S. Sens. Trent Lott and John Breaux to ...
Covidien plc (Dublin, Ireland) has announced that FDA has approved its Apollo Onyx delivery microcatheter, the first detachable-tip microcatheter available in the United States. The new microcatheter is designed to mitigate the technical ...
Tags: Microcatheter, Health, Medicine
Two new reports from iData Research cover the US market for vascular access devices and the European markets for cardiac surgery and heart valve devices. The European interventional cardiology report covers markets for tissue heart ...
Tags: Medtech Markets, US market
There were several in the past few months alone – Covidien acquired Given Imaging for $860 million (this is Covidien’s fourth Israeli company acquisition in a little over 18 months); Baxter acquired FlowSense for $9.5 million; ...
Tags: medical technology, medical device